“Effect of Upadacitinib on Biomarkers of Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis”, J of Skin, vol. 10, no. 2, p. s742, Mar. 2026, doi: 10.25251/y5v7d428.